Zydus Lifesciences Limited (ZYDUSLIFE) Price & Analysis

Compare

3 Followers

ZYDUSLIFE Stock Chart & Stats

Day’s Range― - ―

52-Week Range₹797.05 - ₹1,323.90

Previous CloseN/A

Volume1.39M

Average Volume (3M)55.62K

Market Cap

₹973.18B

Enterprise Value₹976.24B

Total Cash (Recent Filing)₹78.08B

Total Debt (Recent Filing)₹32.13B

Price to Earnings (P/E)21.5

Beta0.60

Next Earnings

Aug 06, 2025

EPS Estimate

13.59

Next Dividend Ex-Date

Jul 25, 2025

Dividend Yield0.31%

Share Statistics

EPS (TTM)13.80

Shares Outstanding1,006,234,000

10 Day Avg. Volume55,092

30 Day Avg. Volume55,616

Financial Highlights & Ratios

PEG Ratio50.70

Price to Book (P/B)4.06

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹1,088.33

Price Target Upside23.29% Upside

Rating ConsensusHold

Number of Analyst Covering3

Zydus Lifesciences Limited News

PremiumCompany Announcements

Zydus Lifesciences Issues Notice on Lost Share Certificate

17d ago

PremiumCompany Announcements

Zydus Lifesciences Addresses USFDA Inspection Observations at Gujarat Facility

3M ago

PremiumCompany Announcements

Zydus Lifesciences Announces Loss of Share Certificate

4M ago

PremiumCompany Announcements

Zydus Lifesciences Gains USFDA Approval for Eluxadoline Tablets

4M ago

PremiumCompany Announcements

Zydus Lifesciences Achieves Successful USFDA Inspection at Ankleshwar Facility

4M ago

PremiumCompany Announcements

Zydus Lifesciences Gains USFDA Approval for Methenamine Hippurate Tablets

4M ago

PremiumCompany Announcements

Zydus Lifesciences Unveils Financial Results for Q3 & 9M FY25

5M ago

PremiumCompany Announcements

Zydus Lifesciences Reports Strong Q3 Financial Growth

5M ago

See All IN:ZYDUSLIFE News

See All News >

Financials

Income Statement >

ZYDUSLIFE FAQ

What was Zydus Lifesciences Limited’s price range in the past 12 months?

Zydus Lifesciences Limited lowest stock price was ₹797.05 and its highest was ₹1323.90 in the past 12 months.

What is Zydus Lifesciences Limited’s market cap?

Zydus Lifesciences Limited’s market cap is ₹973.18B.

When is Zydus Lifesciences Limited’s upcoming earnings report date?

Zydus Lifesciences Limited’s upcoming earnings report date is Aug 06, 2025 which is in 19 days.

How were Zydus Lifesciences Limited’s earnings last quarter?

Zydus Lifesciences Limited released its earnings results on May 20, 2025. The company reported ₹13.8 earnings per share for the quarter, beating the consensus estimate of ₹13.16 by ₹0.64.

Is Zydus Lifesciences Limited overvalued?

According to Wall Street analysts Zydus Lifesciences Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Zydus Lifesciences Limited pay dividends?

Zydus Lifesciences Limited pays a Annually dividend of ₹3 which represents an annual dividend yield of 0.31%. See more information on Zydus Lifesciences Limited dividends here

What is Zydus Lifesciences Limited’s EPS estimate?

Zydus Lifesciences Limited’s EPS estimate is 13.59.

How many shares outstanding does Zydus Lifesciences Limited have?

Zydus Lifesciences Limited has 1,006,234,000 shares outstanding.

What happened to Zydus Lifesciences Limited’s price movement after its last earnings report?

Zydus Lifesciences Limited reported an EPS of ₹13.8 in its last earnings report, beating expectations of ₹13.16. Following the earnings report the stock price went down -3.144%.

Which hedge fund is a major shareholder of Zydus Lifesciences Limited?

Currently, no hedge funds are holding shares in IN:ZYDUSLIFE

Company Description

Zydus Lifesciences Limited

Zydus Lifesciences Limited (ZYDUSLIFE), formerly known as Cadila Healthcare Limited, is a leading Indian pharmaceutical company that operates in the healthcare and life sciences sectors. The company is engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including active pharmaceutical ingredients (APIs), generic formulations, specialty drugs, and biosimilars. Zydus Lifesciences is committed to improving global healthcare through innovative and affordable medicines, serving both domestic and international markets.

ZYDUSLIFE Stock 12 Month Forecast

Average Price Target

₹1,088.33

▲(23.29%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"849":"₹849","1366":"₹1,366","978.25":"₹978.3","1107.5":"₹1,107.5","1236.75":"₹1,236.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1365,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.36K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1088.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.09K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":850,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹850.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[849,978.25,1107.5,1236.75,1366],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Feb<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1001.45,1029.4153846153847,1057.3807692307694,1085.3461538461538,1113.3115384615385,1141.2769230769231,1169.2423076923078,1197.2076923076922,1225.173076923077,1253.1384615384616,1281.1038461538462,1309.0692307692307,1337.0346153846153,{"y":1365,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1001.45,1008.1330769230769,1014.8161538461538,1021.4992307692307,1028.1823076923076,1034.8653846153845,1041.5484615384614,1048.2315384615385,1054.9146153846154,1061.5976923076923,1068.2807692307692,1074.9638461538461,1081.646923076923,{"y":1088.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1001.45,989.8000000000001,978.1500000000001,966.5,954.85,943.2,931.5500000000001,919.9,908.25,896.6,884.95,873.3,861.65,{"y":850,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":998.21,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1064.29,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1241.6,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1111.5,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1080.6,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1001.85,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":974.65,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":973.65,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":973.65,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":970,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":876.2,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":887.7,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1001.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >